Using convalescent plasma transfusion as adjunctive therapy may not help prevent disease progression among hospitalized coronavirus disease (COVID-19) patients, the Department of Science and Technology (DOST) said Thursday, Dec. 9. (Photo by Rodrigo ARANGUA / AFP / MANILA BULLETIN) Results of the...
The Department of Science and Technology (DOST) disclosed on Friday, July 23, the completion of the country’s clinical trial on the efficacy and safety of convalescent plasma transfusion as adjunctive therapy to prevent disease progression among hospitalized coronavirus disease (COVID-19)...
Raymundo W. Lo, MD More than a year into the COVID-19 pandemic, where is the Philippines heading — or more precisely, where is it not heading? Let’s look at several aspects. On the medical front, we now know more about how to treat COVID-19. What works and what doesn’t. Our doctors can...